US FDA declines to approve Disc Medicine's rare disease drug
Feb 13 (Reuters) - Disc Medicine IRON.O said on Friday the U.S. Food and Drug Administration has declined to approve its drug to treat a rare genetic disorder. (Reporting by Sneha S K; Editing by Vijay Kishore) ((Sneha.SK@thomsonreuters.com;))